⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 34 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT January 10, 2024

Meriofert 75 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 75 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)

📷 EU Safety Watch placeholder
Meriofert 75 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 75 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)
📷 EU Safety Watch placeholder
Meriofert 75 IU powder and solvent for injection solution is temporarily unavailable.
🗄
Archived (older alert)
This alert was reported 979 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
120 days in total
May 18, 2026 September 15, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Meriofert is a medicine used to help women have babies. It comes as a powder and liquid that are mixed and given as a shot.

What's happening? The company has stopped making Meriofert for now. It will not be available until at least 2039.

Does this affect me? If you use Meriofert in Austria, this shortage will affect you.

What should I do? Talk to your doctor or pharmacist about other treatment options.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
GONADOTROPES HORMON
Agency-published detail

ATC: G03GA02 · Reason: Vorübergehende Einstellung des Inverkehrbringens · Marketing authorisation holder: IBSA Farmaceutici Italia S.r.l., Via Martiri Di Cefalonia 2, 26900 Lodi, Italien · Affected packs: 10 Stück Schachtel, Durchstechflasche, Ampulle [Nicht verfügbar, since 2024-01-10, resupply 2039-01-10]

First published
January 10, 2024
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Meriofert 75 I.E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 75 IE (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung). Meriofert 75 IU powder and solvent for injection solution is temporarily unavailable.
▸ When was this alert issued?
This alert was issued on January 10, 2024 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.